How much funding has Relay Therapeutics raised?

Relay Therapeutics has raised $520.0M in total funding, most recently a Series C round.

Who are Relay Therapeutics's investors?

Relay Therapeutics's investors include SoftBank, BVF Partners, Third Rock Ventures.

When was Relay Therapeutics founded?

Relay Therapeutics was founded in 2015.

Where is Relay Therapeutics headquartered?

Relay Therapeutics is headquartered in Cambridge, Massachusetts, United States.

What industry is Relay Therapeutics in?

Relay Therapeutics operates in Biotech, Drug Discovery, Healthcare, Therapeutics.

How many employees does Relay Therapeutics have?

Relay Therapeutics has 51-200 employees.

Relay Therapeutics

IPO

Transforming drug discovery

Public · Cambridge, United States · Founded 2015 · $520.0M raised

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2015
Business Model: B2B
Website: relaytx.com

Total Funding: $520.0M
Last Round: $400.0M Series CDec 2018
Rounds: 3
Type: Public

About

Relay Therapeutics is a clinical-stage precision medicines company that integrates leading-edge computational and experimental technologies through its proprietary Dynamo Platform. The platform models protein motion to identify and drug previously intractable targets. Its pipeline is focused on precision oncology and genetic disease, with multiple programs in clinical development including collaborations with major pharma partners.

Summary

Relay Therapeutics is a Biotech company based in Cambridge, United States, founded in 2015. It has raised $520.0M in total across 3 rounds, most recently a $400.0M Series C round in Dec 2018. Investors include SoftBank, BVF Partners and Third Rock Ventures.

LinkedIn X (Twitter)